Next Medical, an Italian value-added distributor of medical devices and surgical tools operating in the fields of orthopedics, traumatology and plastic surgery, was sold to OMX Group.

The acquisition of Next Medical strengthens OMX’s international footprint and expands its platform into the Italian market, adding Next Medical’s specialized expertise and portfolio of medical device brands to the group’s growing European network. OMX’s ambition is to act as a strategic partner for healthcare practitioners and manufacturers, with the ultimate goal of contributing to the efficiency of the healthcare ecosystem. 

As part of the transaction, Tommaso Cherubino, CEO of Next Medical, will become a significant shareholder of the Group, will continue to operate and develop Next Medical, and will benefit from significant resources to accelerate the growth of the business both organically and through M&A, holding also a coordinating role for OMX Group in the orthopedic segment.

The Mid Cap Advisory team of EQUITA, the Italian partner of Clairfield International, and Clairfield France acted as financial advisors for Next Medical. TARGET acted as legal advisor, while Russo De Rosa Associati acted as tax advisor. Malnati & Partners provided accounting advice.
OMX Group was advised by Lamartine Conseil and L&B Partners Avvocati Associati as legal advisors and by KPMG for the financial due dilligence.

Founded in 2010 by Tommaso Cherubino, Next Medical has built a specialized portfolio of high-end medical device brands, providing distribution, technical assistance, training and support to healthcare professionals. The company’s portfolio notably includes Acumed, specialized in plates and screws for orthopedics and traumatology, MicroAire, focused on hand surgery, plastic surgery and power-assisted liposuction systems and Austofix, leading player in intramedullary nailing for traumatology.

Founded in 2023 by Thomas Ringeisen and Léo Spector and backed by Entrepreneur Invest and ISAI as shareholders, and Kartesia and Arkea as financial partners, OMX Group is the largest specialty MedTech distribution group in France. The Group currently operates in seven therapeutic areas encompassing ophthalmology, ENT and maxillofacial surgery, medical imaging and radiotherapy, physiotherapy, medical aesthetics, homecare and defibrillation. The group is pursuing an active buy-and-build strategy through 14 acquisitions, bringing together market leading companies while preserving their brands, expertise and teams, and supporting their growth through shared resources and financial capabilities.